PLATINUM INVESTMENT MANAGEMENT LTD - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$3,125,727
-35.2%
3,189,517
-8.1%
0.12%
-26.9%
Q2 2023$4,822,791
+17.5%
3,469,634
+34.5%
0.17%
+17.6%
Q1 2023$4,103,114
-53.9%
2,580,575
+80.5%
0.14%
-58.2%
Q4 2022$8,908,906
-7.0%
1,430,0010.0%0.34%
-15.0%
Q3 2022$9,581,000
-7.2%
1,430,001
-11.9%
0.40%
+2.6%
Q2 2022$10,325,000
-18.0%
1,623,440
-40.2%
0.39%
+1.0%
Q1 2022$12,589,000
-7.2%
2,713,1760.0%0.39%
+2.1%
Q4 2021$13,566,000
-34.3%
2,713,176
+58.4%
0.38%
-34.9%
Q3 2021$20,644,000
-43.0%
1,713,1760.0%0.58%
-30.7%
Q2 2021$36,234,000
-19.3%
1,713,176
+7.0%
0.84%
-16.4%
Q1 2021$44,897,000
+10.5%
1,600,613
+2.4%
1.00%
+7.3%
Q4 2020$40,635,000
+26.1%
1,562,869
+80.3%
0.93%
+17.2%
Q3 2020$32,215,000
-26.3%
866,681
+1.8%
0.80%
-20.1%
Q2 2020$43,688,000
+70.7%
851,453
+4.9%
1.00%
+54.3%
Q1 2020$25,593,000
+1016.1%
811,692
+2010.8%
0.65%
+1335.6%
Q4 2019$2,293,00038,4540.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2020
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders